Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed patients with mullerian tumors.
Journal: International journal of clinical oncology
Published: February 17, 2022
A phase I study of AZD2171 and Temsirolimus in patients with advanced gynecological malignancies.
Journal: Cancer chemotherapy and pharmacology
Published: August 12, 2021
Ofranergene obadenovec (VB-111) in platinum-resistant ovarian cancer; favorable response rates in a phase I/II study are associated with an immunotherapeutic effect.
Journal: Gynecologic oncology
Published: January 20, 2020
Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody-drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 05, 2016
Molecular Characterization of an Endometrial Endometrioid Adenocarcinoma Metastatic to a Thyroid Hürthle Cell Adenoma Showing Cancerization of Follicles.
Journal: Endocrine pathology
Published: December 22, 2015
Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies.
Journal: The journal of allergy and clinical immunology. In practice
Published: August 04, 2015
Phase I study of combination of vorinostat, carboplatin, and gemcitabine in women with recurrent, platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancer.
Journal: Cancer chemotherapy and pharmacology
Published: June 04, 2015
Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions.
Journal: The Journal of allergy and clinical immunology
Published: April 25, 2015
Using FastTrack to Implement an Academic Medical Center and Community Health Center Collaborative for Cancer Care Delivery.
Journal: Healthcare (Amsterdam, Netherlands)
Published: February 12, 2014
A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer.
Journal: Gynecologic oncology
Published: July 24, 2013
A novel community-based delivery model to combat cancer disparities.
Journal: Healthcare (Amsterdam, Netherlands)
Published: May 17, 2013
Typical and atypical metastatic sites of recurrent endometrial carcinoma.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: April 03, 2013
Last Updated: 09/26/2026